ARQ197 Ph 1/2 Placebo-Controlled ARQ197, Irinotecan & Cetuximab Colorectal Ca w/ Wild-type KRAS s/p Txmt

  • Jones, Dennie (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date11/1/113/31/12